Deutsche Bank Ag\ Surmodics Inc Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Surmodics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 5,963 shares of SRDX stock, worth $229,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,963

Previous 51,362 88.39%

Holding current value

$229,396

Previous $1.51 Million 83.4%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $1.15 Million - $1.91 Million	-45,399 Reduced 88.39%	5,963 $250,000
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $1.86 Million - $2.41 Million	-67,770 Reduced 56.89%	51,362 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$28.47 - $38.49 $3.19 Million - $4.31 Million	112,055 Added 1583.37%	119,132 $4.33 Million
Q3 2023 Nov 09, 2023	BUY	$28.28 - $38.36 $31,334 - $42,502	1,108 Added 18.56%	7,077 $227,000
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $116,639 - $206,677	-6,601 Reduced 52.51%	5,969 $186,000
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $97,932 - $220,218	5,717 Added 83.42%	12,570 $286,000
Q4 2022 Feb 13, 2023	BUY	$29.44 - $37.31 $3,503 - $4,439	119 Added 1.77%	6,853 $233,000
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $25,408 - $34,288	-881 Reduced 11.57%	6,734 $205,000
Q2 2022 Aug 11, 2022	SELL	$33.25 - $45.11 $10,706 - $14,525	-322 Reduced 4.06%	7,615 $284,000
Q1 2022 May 13, 2022	SELL	$40.68 - $49.72 $35,798 - $43,753	-880 Reduced 9.98%	7,937 $360,000
Q4 2021 Feb 11, 2022	BUY	$43.21 - $57.6 $19,660 - $26,208	455 Added 5.44%	8,817 $424,000
Q3 2021 Nov 04, 2021	SELL	$52.8 - $60.32 $29,304 - $33,477	-555 Reduced 6.22%	8,362 $465,000
Q2 2021 Aug 11, 2021	SELL	$51.29 - $59.15 $22,772 - $26,262	-444 Reduced 4.74%	8,917 $483,000
Q1 2021 May 13, 2021	SELL	$42.18 - $56.07 $1.29 Million - $1.72 Million	-30,624 Reduced 76.59%	9,361 $524,000
Q4 2020 Feb 16, 2021	BUY	$35.18 - $43.52 $89,638 - $110,888	2,548 Added 6.81%	39,985 $1.74 Million
Q3 2020 Nov 12, 2020	SELL	$37.98 - $48.72 $45,538 - $58,415	-1,199 Reduced 3.1%	37,437 $1.46 Million
Q2 2020 Aug 13, 2020	SELL	$31.07 - $44.74 $2.88 Million - $4.15 Million	-92,736 Reduced 70.59%	38,636 $1.67 Million
Q1 2020 May 14, 2020	BUY	$22.46 - $42.24 $1.77 Million - $3.33 Million	78,776 Added 149.78%	131,372 $4.38 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $105,912 - $128,989	-2,715 Reduced 4.91%	52,596 $2.18 Million
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $1.1 Million - $1.35 Million	-28,563 Reduced 34.05%	55,311 $2.53 Million
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $3.7 Million - $4.58 Million	-96,668 Reduced 53.54%	83,874 $3.62 Million
Q1 2019 May 15, 2019	BUY	$41.26 - $58.35 $3.19 Million - $4.52 Million	77,399 Added 75.04%	180,542 $7.85 Million
Q4 2018 Feb 14, 2019	SELL	$44.93 - $73.38 $5.26 Million - $8.59 Million	-117,069 Reduced 53.16%	103,143 $4.87 Million
Q3 2018 Dec 21, 2021	BUY	$56.85 - $80.35 $8.85 Million - $12.5 Million	155,669 Added 241.19%	220,212 $16.4 Million
Q3 2018 Nov 14, 2018	SELL	$56.85 - $80.35 $447,352 - $632,274	-7,869 Reduced 10.87%	64,543 $4.82 Million
Q2 2018 Apr 21, 2020	BUY	$35.85 - $57.05 $969,061 - $1.54 Million	27,031 Added 59.56%	72,412 $4 Million
Q2 2018 Aug 14, 2018	SELL	$35.85 - $57.05 $182,333 - $290,156	-5,086 Reduced 10.08%	45,381 $2.5 Million
Q1 2018 Oct 18, 2019	BUY	$27.0 - $38.5 $857,817 - $1.22 Million	31,771 Added 169.93%	50,467 $1.92 Million
Q1 2018 May 15, 2018	SELL	$27.0 - $38.5 $821,421 - $1.17 Million	-30,423 Reduced 61.94%	18,696 $710,000
Q4 2017 Feb 14, 2018	BUY	$28.0 - $33.2 $110,012 - $130,442	3,929 Added 8.69%	49,119 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $1.11 Million - $1.41 Million	45,190	45,190 $1.4 Million

Others Institutions Holding SRDX

# of Institutions

124

Shares Held

13.2M

Call Options Held

25.5K

Put Options Held

3.4K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $539M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account